Effectiveness and Safety Outcomes in Patients with EBV+ PTLD Treated with Allogeneic EBV-specific T-cell Immunotherapy (tabelecleucel) under an Expanded Access Program (EAP) in Europe.
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
T Cell Therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要